Amyloid imaging in dementias with atypical presentation
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background: With the potential emergence of disease specific therapies, an accurate biomarker of Alzheimer's Disease pathology is needed in cases in which the underlying etiology is uncertain. We explored the potential value of amyloid imaging in patients with atypical presentations of dementia. Methods: Twenty‐eight patients with atypical dementia underwent positron emission tomography imaging with the amyloid imaging tracer Pittsburgh compound B (PiB). Twenty‐six had [18F]fluoro‐2‐deoxy‐D‐glucose positron emission tomography scans. After extensive clinical evaluation, this group of patients generated considerable diagnostic uncertainty and received working diagnoses that included possible Alzheimer's disease (AD), focal dementias (e.g., posterior cortical atrophy [PCA]), or cases in which no clear diagnostic category could be determined (dementia of uncertain etiology). Patients were classified as PiB‐positive, PiB‐negative, or PiB‐intermediate, based on objective criteria. Anterior–posterior and left–right indices of PiB and [18F]fluoro‐2‐deoxy‐D‐glucose uptake were calculated to examine differences in distribution of amyloid pathology and metabolic changes associated with clinical phenotype. Results: Eleven patients (39%) were PiB positive, 16 were PiB negative (57%), and one (4%) was PiB intermediate. By diagnostic category, three of 10 patients (30%) with dementia of uncertain etiology, one of five (20%) with primary progressive aphasia, three of five (60%) with PCA, and four of seven (57%) with possible AD were PiB positive. Brain metabolism of both PiB‐positive and PiB‐negative patients was generally similar by phenotype, but appeared to differ from typical AD. PCA patients also appeared to differ in their relative distribution of PiB compared with typical AD, consistent with their atypical phenotype. Conclusions: AD pathology is frequently present in atypical presentations of dementia and can be identified by amyloid imaging. Clinical phenotype is more related to the pattern of cerebral hypometabolism than the presence/absence of amyloid pathology. These findings have diagnostic, prognostic, and therapeutic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“Findings of PiB retention in a pattern consistent with pathologic descriptions of amyloid plaque distribution in AD [9–12], high correlations between autopsy-determined regional concentrations of plaque load and in vivo PiB PET [13,14], and an increased risk of conversion to AD in mild cognitive impairment patients wi…”
ResultImaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Self-citationMorris, J. C., Weintraub, S., Chui, H. C., Cummings, J., DeCarli, C., Ferris, S., Foster, N. L., Galasko, D., Graff-Radford, N., Peskind, E. R., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213865.09806.92 · Cited by 950
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · cited 12×
“Twenty-eight patients with an atypical or a focal form of dementia (mean: 64.6 6 10.3 [SD] years; 14 females) were recruited for PiB PET imaging.”
ResultInfluentialSelf-citationThe evolution and pathology of frontotemporal dementia
Kertesz, A., McMonagle, P., Blair, M., Davidson, W., & Munoz, D. G. (2005) · Brain · doi:10.1093/brain/awh598 · Cited by 609
Focal cortical presentations of Alzheimer's disease
Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K., & Hodges, J. R. (2007) · Brain · doi:10.1093/brain/awm213 · Cited by 581 · cited 2×
“For example, in the series by Alladi et al [3], more than 40% of patients with progressive nonfluent aphasia had AD pathology rather than the expected frontotemporal lobar degeneration pathology.”
BackgroundAlzheimer and frontotemporal pathology in subsets of primary progressive aphasia
Mesulam, M., Wicklund, A., Johnson, N., Rogalski, E., Léger, G. C., Rademaker, A., Weintraub, S., & Bigio, E. H. (2008) · Annals of Neurology · doi:10.1002/ana.21388 · Cited by 513
Frontotemporal dementia: Clinicopathological correlations
Forman, M. S., Farmer, J., Johnson, J. K., Clark, C. M., Arnold, S. E., Coslett, H. B., Chatterjee, A., Hurtig, H. I., Karlawish, J. H., Rosen, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20873 · Cited by 478
Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
Rabinovici, G. D., Jagust, W. J., Furst, A. J., Ogar, J. M., Racine, C. A., Mormino, E. C., O'Neil, J. P., Lal, R. A., Dronkers, N. F., Miller, B. L., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21451 · Cited by 477
Research works printed but not linked: 36
- 10.1111/j.1365-2796.2004.01380.x · DOI · Paper page
- 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
- 10.1007/s00401-007-0266-x · DOI · Paper page
- 10.1212/WNL.55.12.1854 · DOI · Paper page
- 10.1016/S0197-4580(00)00183-4 · DOI · Paper page
- 10.1002/ana.20009 · DOI · Paper page
- 10.1093/brain/awl178 · DOI · Paper page
- 10.1001/archneur.64.3.431 · DOI · Paper page
- 10.1016/j.neurobiolaging.2007.03.029 · DOI · Paper page
- 10.1002/ana.21598 · DOI · Paper page
- 10.1212/WNL.0b013e3181b23564 · DOI · Paper page
- WJJagust DBandy KChen NLFoster SMLandau CAMathis et al.The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement;6:221–229. · DOI · Paper page
- 10.1159/000163927 · DOI · Paper page
- 10.1001/archneur.64.8.1140 · DOI · Paper page
- 10.1007/s00259-007-0523-1 · DOI · Paper page
- 10.1212/01.wnl.0000259035.98480.ed · DOI · Paper page
- 10.2967/jnumed.106.037762 · DOI · Paper page
- McKhann G, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS‐ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 285, 10.1212/WNL.34.7.939 · DOI · Paper page
- Mesulam MM, 2003, The core and halo of primary progressive aphasia and semantic dementia, Ann Neurol, 54, S11, 10.1002/ana.10569 · DOI
- 10.1212/01.wnl.0000196477.78548.db · DOI · Paper page
- 10.1212/WNL.51.6.1546 · DOI · Paper page
- Lopresti BJ, 2005, Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis, J Nucl Med, 46, 1959
- 10.1038/sj.jcbfm.9600146 · DOI · Paper page
- 10.1109/23.873020 · DOI · Paper page
- Meltzer CC, 1999, Comparative evaluation of MR‐based partial‐volume correction schemes for PET, J Nucl Med, 40, 2053
- 10.1001/archneur.65.11.1509 · DOI · Paper page
- 10.1002/ana.20700 · DOI · Paper page
- 10.1212/01.WNL.0000140289.18472.15 · DOI · Paper page
- 10.1016/j.neurobiolaging.2007.02.016 · DOI · Paper page
- 10.1016/j.neuint.2009.02.017 · DOI
- 10.1097/00005072-199003000-00008 · DOI · Paper page
- Tenovuo O, 2008, Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid‐beta accumulation, J Alzheimers Dis, 15, 351, 10.3233/JAD-2008-15301 · DOI · Paper page
- 10.1212/WNL.40.3_Part_1.423 · DOI · Paper page
- Galton CJ, 2000, Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases, Brain, 123, 484, 10.1093/brain/123.3.484 · DOI · Paper page
- 10.1016/S0197-4580(97)85095-6 · DOI
- 10.1002/ana.10825 · DOI · Paper page
Cited by
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., O’Neil, J. P., Janabi, M., Lazaris, A., Cantwell, A., et al. (2016) · Brain · doi:10.1093/brain/aww027 · Cited by 1,185
“…research, however, is the disconnection between the diffuse distribution of amyloid-b pathology throughout the neocortex (Rabinovici et al., 2010; Wolk et al., 2012; Lehmann et al., 2013; Jung et al., 2015) and the selective patterns of brain atrophy and glucose hypometabolism that…”
BackgroundInfluentialBiomarker Modeling of Alzheimer’s Disease
Jack, C. R., & Holtzman, D. M. (2013) · Neuron · doi:10.1016/j.neuron.2013.12.003 · Cited by 1,002
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
Villemagne, V. L., Doré, V., Burnham, S. C., Masters, C. L., & Rowe, C. C. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2018.9 · Cited by 441
Xia, C., Makaretz, S. J., Caso, C., McGinnis, S., Gomperts, S. N., Sepulcre, J., Gomez-Isla, T., Hyman, B. T., Schultz, A., Vasdev, N., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5755 · Cited by 282
Metadata
- Authors
- Wolk, D. A., Price, J. C., Madeira, C., Saxton, J. A., Snitz, B. E., Lopez, O. L., Mathis, C. A., Klunk, W. E., & DeKosky, S. T.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2012-01-30
- Volume
- 8
- Issue
- 5
- Pages
- 389-398
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2033010759
- Cited by
- 49
- References
- 13
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Institutes of Health (P50 AG005133, P01 AG025204, K23 AG028018)
- Pennsylvania Department of Health (SAP 4100027294)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloid imaging in dementias with atypical presentation. https://app.cochat.ai/papers/10.1016/j.jalz.2011.07.003
- The paper
- Wolk, D. A., Price, J. C., Madeira, C., Saxton, J. A., Snitz, B. E., Lopez, O. L., Mathis, C. A., Klunk, W. E., & DeKosky, S. T. (2012). Amyloid imaging in dementias with atypical presentation. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2011.07.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.